Last reviewed · How we verify
Conventional antihypertensive drugs
Conventional antihypertensive drugs lower blood pressure through various mechanisms including vasodilation, reduced cardiac output, or decreased peripheral vascular resistance.
Conventional antihypertensive drugs lower blood pressure through various mechanisms including vasodilation, reduced cardiac output, or decreased peripheral vascular resistance. Used for Hypertension, Blood pressure management.
At a glance
| Generic name | Conventional antihypertensive drugs |
|---|---|
| Also known as | any antihypertensive drug except ARB |
| Sponsor | KVT-Study Group |
| Drug class | Antihypertensive agents (mixed class category) |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This is a broad category encompassing multiple drug classes (ACE inhibitors, beta-blockers, calcium channel blockers, diuretics, alpha-blockers) that work through distinct mechanisms to reduce blood pressure. They may act by inhibiting the renin-angiotensin system, blocking sympathetic nervous system activity, dilating blood vessels, or reducing blood volume. The KVT-Study Group likely evaluated one or more of these established antihypertensive classes in a clinical trial.
Approved indications
- Hypertension
- Blood pressure management
Common side effects
- Dizziness or lightheadedness
- Fatigue
- Headache
- Cough (ACE inhibitors)
- Edema (calcium channel blockers)
- Hypotension
Key clinical trials
- Intensive Versus Conventional Blood Pressure Control Following Stroke Thrombectomy (NA)
- The Use of Virtual Reality and Music Therapy for Hypertensive Urgency (NA)
- The Correlation and Mechanistic Study of GGCX Gene With Prognosis in Acute Ischemic Stroke
- Antihypertensive Drug Selection Based on Hemodynamic Phenotypes (PHASE4)
- Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma (PHASE2)
- Nebivolol ANOCA Treatment Randomized Trial (PHASE3)
- Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses (NA)
- Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION） (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Conventional antihypertensive drugs CI brief — competitive landscape report
- Conventional antihypertensive drugs updates RSS · CI watch RSS
- KVT-Study Group portfolio CI